Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Direct Biologics, LLC
- Links
- Direct Biologics, LLC
- ID
- NCT05354141
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 970 study participants
- Last Updated